 The main purpose of this study is to describe activity and toxicity of single-agent gemcitabine given as prolonged infusion, and of two 2-drug combinations containing cisplatin cisplatin vinorelbine, and cisplatin gemcitabine in the treatment of elderly patients with advanced non small cell lung cancer 